Ferric derisomaltose, sold under the brand name Monoferric among others, is a medication for the treatment of iron deficiency anemia in adults who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent chronic kidney disease (NDD-CKD).
[4] It was approved for use in the United States in January 2020.
[4][5][6] It is given intravenously.
This drug article relating to the blood and blood forming organs is a stub.
You can help Wikipedia by expanding it.